Crossref Cited-by Linking logo

Collect. Czech. Chem. Commun. 2006, 71, 1099-1106
https://doi.org/10.1135/cccc20061099

New N4-Hydroxycytidine Derivatives: Synthesis and Antiviral Activity

Maksim A. Ivanova, Elena V. Antonovaa, Aleksey V. Maksimova, Lyudmila K. Pigusovaa, Evgenii F. Belanovb and Lyudmila A. Aleksandrovaa,*

a Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 32 Vavilov Str., Moscow 119991, Russian Federation
b State Research Center of Virology and Biotechnology "Vektor", Koltsovo, Novosibirsk Region 633159, Russian Federation

Crossref Cited-by Linking

  • An Yeon Jin, Choi Se Myeong, Choi Eun Rang, Nam Ye Eun, Seo Eun Woo, Ahn Soo Bin, Jang Yejin, Kim Meehyein, Cho Jong Hyun: Synthesis and biological evaluation of new β-D-N4-hydroxycytidine analogs against SARS-CoV-2, influenza viruses and DENV-2. Bioorganic & Medicinal Chemistry Letters 2023, 83, 129174. <https://doi.org/10.1016/j.bmcl.2023.129174>
  • Khiali Sajad, Khani Elnaz, B Rouy Samineh, Entezari-Maleki Taher: Comprehensive Review on Molnupiravir in COVID-19: A Novel Promising Antiviral to Combat the Pandemic. Future Microbiol. 2022, 17, 377. <https://doi.org/10.2217/fmb-2021-0252>
  • Painter George R, Natchus Michael G, Cohen Oren, Holman Wendy, Painter Wendy P: Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19. Current Opinion in Virology 2021, 50, 17. <https://doi.org/10.1016/j.coviro.2021.06.003>
  • Vasudevan N., Ahlqvist Grace P., McGeough Catherine P., Paymode Dinesh J., Cardoso Flavio S. P., Lucas Tobias, Dietz Jule-Phillip, Opatz Till, Jamison Timothy F., Gupton Frank B., Snead David R.: A concise route to MK-4482 (EIDD-2801) from cytidine. Chem. Commun. 2020, 56, 13363. <https://doi.org/10.1039/D0CC05944G>
  • Painter George R., Bowen Richard A., Bluemling Gregory R., DeBergh John, Edpuganti Vindhya, Gruddanti Prabhakar R., Guthrie David B., Hager Michael, Kuiper Damien L., Lockwood Mark A., Mitchell Deborah G., Natchus Michael G., Sticher Zachary M., Kolykhalov Alexander A.: The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection. Antiviral Research 2019, 171, 104597. <https://doi.org/10.1016/j.antiviral.2019.104597>
  • Kozlovskaya Liubov I., Golinets Anastasia D., Eletskaya Anastasia A., Orlov Alexey A., Palyulin Vladimir A., Kochetkov Sergey N., Alexandrova Liudmila A., Osolodkin Dmitry I.: Selective Inhibition of Enterovirus A Species Members’ Reproduction by Furano[2, 3‐d]pyrimidine Nucleosides Revealed by Antiviral Activity Profiling against (+)ssRNA Viruses. ChemistrySelect 2018, 3, 2321. <https://doi.org/10.1002/slct.201703052>
  • Maruoka Hiroshi, Barrett Matthew O., Ko Hyojin, Tosh Dilip K., Melman Artem, Burianek Lauren E., Balasubramanian Ramachandran, Berk Barkin, Costanzi Stefano, Harden T. Kendall, Jacobson Kenneth A.: Pyrimidine Ribonucleotides with Enhanced Selectivity as P2Y6 Receptor Agonists: Novel 4-Alkyloxyimino, (S)-Methanocarba, and 5′-Triphosphate γ-Ester Modifications. J. Med. Chem. 2010, 53, 4488. <https://doi.org/10.1021/jm100287t>
  • Ko Hyojin, Das Arijit, Carter Rhonda L., Fricks Ingrid P., Zhou Yixing, Ivanov Andrei A., Melman Artem, Joshi Bhalchandra V., Kováč Pavol, Hajduch Jan: Molecular recognition in the P2Y14 receptor: Probing the structurally permissive terminal sugar moiety of uridine-5′-diphosphoglucose. biorg med chem 2009, 17, 5298. <https://doi.org/10.1016/j.bmc.2009.05.024>
  • Ivanov Maksim A., Antonova Elena V., Maksimov Aleksey V., Pigusova Lyudmila K., Belanov Evgenii F., Aleksandrova Lyudmila A.: New N4‐Hydroxycytidine Derivatives: Synthesis and Antiviral Activity. ChemInform 2007, 38. <https://doi.org/10.1002/chin.200702195>